Review
Published on 28 Mar 2023
Long noncoding RNA SNHG15: A promising target in human cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1108564
- 2,150 views
- 5 citations
Type at least 3 characters
1,828 articles
Articles
Systematic Review
Published on 27 Mar 2023
Acupuncture therapies for cancer-related fatigue: A Bayesian network meta-analysis and systematic review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1071326
- 4,749 views
- 4 citations
Original Research
Published on 27 Mar 2023
Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1157115
- 2,372 views
- 4 citations
Review
Published on 27 Mar 2023
MACC1-induced migration in tumors: Current state and perspective
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1165676
- 2,115 views
- 6 citations
Original Research
Published on 24 Mar 2023
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1139588
- 2,026 views
- 2 citations
Review
Published on 24 Mar 2023
Application status and future prospects of the PDX model in lung cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1098581
- 3,989 views
- 7 citations
Brief Research Report
Published on 23 Mar 2023
B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1145724
- 2,067 views
- 1 citation
Case Report
Published on 23 Mar 2023
Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1147974
- 2,398 views
- 3 citations
Editorial
Published on 22 Mar 2023
Editorial: Pulsed electric field based technologies for oncology applications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1183900
- 3,020 views
- 6 citations
Case Report
Published on 22 Mar 2023
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1084456
- 2,956 views
- 9 citations
Review
Published on 21 Mar 2023
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1133832
- 18,065 views
- 35 citations
Mini Review
Published on 17 Mar 2023
In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1077461
- 3,083 views
- 5 citations
Original Research
Published on 14 Mar 2023
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1140730
- 4,838 views
- 10 citations
Original Research
Published on 13 Mar 2023
High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1085569
- 3,376 views
- 2 citations
Original Research
Published on 10 Mar 2023
Loss of liver kinase B1 in human seminoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1081110
- 1,136 views
Original Research
Published on 10 Mar 2023
LIM1 contributes to the malignant potential of endometrial cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1082441
- 2,421 views
- 3 citations